
Congratulations to our 2026 #AHSAZ award winners! Your work in research, clinical care, and education moves #headachemedicine forward. See you at the Westin Kierland, Dec 3–6! Learn more through our latest article here: bit.ly/489sjog

American Headache Society® professionals dedicated to the study & treatment of #migraine, #headache & facial pain. #AHSAM #AHSAZ @HeadacheJournal

Congratulations to our 2026 #AHSAZ award winners! Your work in research, clinical care, and education moves #headachemedicine forward. See you at the Westin Kierland, Dec 3–6! Learn more through our latest article here: bit.ly/489sjog

#HeadacheHighlights Lifestyle triggers of #migraine: Sleep restriction and caffeine lower the threshold for migraine-like responses in rats in a sex-specific manner Learn more here: bit.ly/4A1C3Nh

East Coast meets West Coast for some friendly rivalry at the Headache Challenge! So fun connecting with residents across programs, sharing our love for headache medicine, and learning from faculty passionate about teaching the next generation of neurologists. #HeadacheEdu

What makes AHS feel like home? Hear from our members about the mentorship, collaboration, and lifelong connections they’ve found while advancing #HeadacheMedicine together. Join AHS or renew your membership today: bit.ly/4hBLDPk

Last call: #HeadacheAcademy applications close Sunday, Oct 25! Open to PGY-3+ residents, headache fellows & MD/PhD clinicians/researchers in training or within 5 yrs of completion, located in the US, Canada, or Latin America. Apply here: bit.ly/4jEZl6z

Friday, Dec 4 is AHS Day at #AHSAZ! Wear your AHS gear to show your AHS pride. Order your swag now so it arrives in time to pack for Scottsdale. Tag us in your photos using #AHSAZ View ShopAHS here: bit.ly/4e9nTky

The AHS LGBTQIA+ Health Special Interest Group advocates for patients and providers who identify as LGBTQIA+, as sexual and gender minorities have a higher incidence of #headachedisorders compared to the general population. Learn more from Dr. Barber here: bit.ly/4hpiyYE

Ready to elevate your headache care? At #AHSAZ, the 2026 Scottsdale Headache Symposium, you can learn the latest in diagnosis and treatment from leading experts, earn CME, and connect with the AHS community. Register by Oct. 29 to save: bit.ly/4hul52k

Happy #NationalPrimaryCareWeek! Thank you to the Primary Care Practitioners who are often the first line of support for patients living with #migraine and #headache disorders. Learn more about free #AHSFirstContact Resources here: bit.ly/4rHp5Bo

Great meeting in Chicago with the @ahsheadache Sci Comm! Looking forward to #San Diego! #migraine @ChiaChunChiang @LeviSowers @HeadacheJournal

Honored to be part of the @ahsheadache Scientific meeting planning committee and already looking forward to the 2027 #AHS annual meeting in San Diego!
Great meeting in Chicago with the @ahsheadache Sci Comm! Looking forward to #San Diego! #migraine @ChiaChunChiang @LeviSowers @HeadacheJournal

AHS 2027 membership renewals are open! Not a member yet? Join today for access to CME, research, networking, and more. Be a part of the community advancing #headachemedicine. Join or renew here to take advantage of all AHS has to offer: bit.ly/4xUDxr0

Join us for the @miles4migraine Run/Walk/Relax on Sat, Dec 5 in conjunction with #AHSAZ! All are welcome to join and raise awareness for #migraine & #headache disorders. Learn more and register today: bit.ly/4fDa7GH Register for #AHSAZ here: bit.ly/4coa94E

Applications now open for AHS’s 2027 Headache Academy! Learn from world-leading experts in migraine, cluster headache & primary headache disorders, plus training in clinical trial methods & research publication. Review the criteria and apply here: bit.ly/4qDDVYQ

Happy #AdvancedPracticeProvidersWeek! AHS celebrates NPs & PAs whose skill and compassion bring relief to patients with #headache and #migraine disease. Learn more about how the AHS APP SIG supports the growing role of APPs in #headachemedicine bit.ly/4rLKtpf

Open Access: How early can function improve w #migraine prevention? Across 3 phase 3 trials, #atogepant was associated w early improvements in daily functioning, w differences emerging w/in first 4 weeks. @rashmihalker @JHCDrScott @DawnBuse Read more: headachejournal.onlinelibrar…